Upgrades

Latest Ratings for CFR

Date Firm Action From To
Jan 2022 Raymond James Upgrades Underperform Market Perform
Dec 2021 Morgan Stanley Maintains Underweight
Nov 2021 Morgan Stanley Maintains Underweight

View More Analyst Ratings for CFR

View the Latest Analyst Ratings

read more

Ambrx Biopharma (NYSE:AMAM)
Historical Stock Chart
Von Jun 2022 bis Jul 2022 Click Here for more Ambrx Biopharma Charts.
Ambrx Biopharma (NYSE:AMAM)
Historical Stock Chart
Von Jul 2021 bis Jul 2022 Click Here for more Ambrx Biopharma Charts.